abstract |
(57) [Summary] [PROBLEMS] To provide a therapeutic agent for an autoimmune disease. SOLUTION: 4- (2-chlorophenyl) -2- (2 -(4-Isobutylphenyl) ethyl) -6,9-dimethyl-6H-thieno [3,2-f] [1,2,4] triazolo [4,3-a] [1,4] diazepine, its optics It has been found that isomers, or their pharmaceutically acceptable acid addition salts or hydrates, can achieve the above objectives. |